Skip to main content
. 2016 Nov 23;7(52):86985–86998. doi: 10.18632/oncotarget.13521

Figure 2. Ctnnb1CA hep mice are characterized by severe cholestasis and qualitative changes in bile acid composition.

Figure 2

Ctnnb1CA hep mice displayed significantly increased serum (A) and hepatic (B) bile acid levels. Expression of Cyp7a1 (C) was significantly increased in Ctnnb1CA hep mice, whereas mRNA levels of Cyp27 (D) and Cyp8b1 (E) were decreased in livers with continuous β-catenin activation. The composition of the bile acid pool was altered in Ctnnb1CA hep mice (F). The percentage of tauro-β-muricholic acid (β-TMCA, G) and β-muricholic acid (β-MCA, H) of the total bile acid pool was significantly increased in Ctnnb1CA hep mice, whereas the percentage of taurine-conjugated cholic acid (TCA, I) and deoxycholic acid (TDCA, J) was decreased.